There are a handful of companies in the robotic surgical space. But that is about to change. There is ample evidence that the robotic surgical device market is going to explode in the next 3 to 5 years. We recently spoke with Todd Pope, CEO of TransEnterix who said there is a lot of opportunity […]
Successful surgical device development is dependent on teasing out, sometimes unknown, needs and is best achieved through direct contextual research. This is especially true for devices to be used within the acute environment of the operating room. With the emergence of robotic technologies, the dynamics within the operating room is changing. In robotic surgery, there […]
Faster than a scalpel-wielding hand, able to snake to hard-to-reach surgical sites in a single bound—future surgeons will be super surgeons, all thanks to robotics. Alistair Fleming, VP Medical at Sagentia In many industries, the advance of robotics has created worries about robots supplanting humans. But in the world of surgery, the next generation of […]
Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve patient outcomes by increasing adherence and reducing dosing variability. Mark David Tuckwell, head of electronics, software & systems at Sagentia, says connected device can also provide crucial information to help […]
by Alistair Fleming, VP Medical, Sagentia Whilst in many industries the advance of robotics has created worries about robots supplanting humans, in the world of surgery, the next generation of robotics is set to do the opposite – to supercharge the surgeon and put him in control as never before. First generation systems The first generation of […]
Sagentia is a company that thrives on complexity. Its business is built around helping both established and emerging technology companies avoid the uncertainties of innovation.
"We operate best where there is a complex scientific or technical problem that needs resolving as part of product development,” CEO Brent Hudson told MassDevice.
Hudson, who joined the research and development consulting firm in 2009, describes the services they offer as having a little ‘r’ and a big ‘D.’
MASSDEVICE ON CALL — Topera Medical, a once-stealthy medical device start-up formerly based in San Diego, hired a former Boston Scientific Corp. (NYSE:BSX) vice president and moved clear across the country.
The firm, now based in Lexington, Mass., is looking to commercialize technology developed by Dr. Sanjiv Narayan at the University of California, San Diego. It hired former Boston Scientific VP Edward Kerslake to be its CEO in December 2010, according to Xconomy.
Brent Hudson is the CEO of technology and product development consulting firm Sagentia and his company is bearing witness to both an improving economy for entrepreneurs and a regulatory system that is becoming harder to grapple with for small companies. Cambridge, U.K.-based Sagentia opened up an office in tech-heavy Cambridge, Mass. in November; Hudson offered his predictions for an industry of whose growth he hopes to take advantage.
T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the development of its portable diagnostics system.
The Cambridge, Mass.-based start-up is developing nano- and miniaturized magnetic resonance-based technology for use in a bench-top instrument for small molecule diagnostics, according to Sagentia.
In May, T2 raised $15 million in a Series C funding round to support the development of the technology.
Sagentia opened up a location in Cambridge, Mass. looking to drum up some local talent.
The Cambridge, U.K.-based firm attributes its latest growth to the North American market and wants to capitalize on the new location’s proximity to "a wealth of world-renowned" research institutions.